Dimerent

Dimerent is a venture capital firm based in Rauma, Finland, that invests in early-stage biotechnology startups. The firm focuses on providing capital to innovative companies developing advanced protein engineering technologies, specialized drug manufacturing processes, and novel therapeutics targeting cancer, infectious diseases, and immunology. Dimerent recently participated in a $5.7 million seed extension funding round for Avenue Biosciences, a protein engineering company. Through this investment, the firm co-invested alongside several notable Nordic venture capital entities and institutions, including Balnord, Tesi, Voima Ventures, and the University of Helsinki. Operating primarily within the broader Helsinki-area biotechnology ecosystem, the firm actively supports early-stage scientific research commercialization, though it operates without publicly disclosing its total assets under management or exact portfolio size. The organization's exact founding year and the specific names of its original founders are not currently disclosed in public records.